Spatial biomarkers of response to eribulin plus pembrolizumab in patients with metastatic triple negative breast cancer in the ENHANCE-1 trial
Yee Hoon Foong(New York University), Eileen P. Connolly(Columbia University Irving Medical Center)
Cited by 0
Related Papers
Tissue-specific Grb10/Ddc insulator drives allelic architecture for cardiac development
|Molecular Cell|2022|33